台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    97.3
  • 漲跌
    ▲1.1
  • 漲幅
    +1.14%
  • 成交量
    724
  • 產業
    上櫃 生技醫療類股
  • 309人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
智擎 (4162)籌碼相關-群益金鼎-瑞豐 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw04/0104/2005/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0402/1602/2603/1003/209095100105110115120125May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

群益金鼎-瑞豐 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/01097.90397.5097.30-31,773-0.17%
2025/03/31897.24597.4096.2031,7710.17%
2025/03/285102.0000.00100.5051,7520.29%
2025/03/270.1103.5000.00103.500.11,7280.00%
2025/03/260105.5000.00104.5001,7230.00%
2025/03/200106.3300.00106.0001,7130.00%
2025/03/170107.0000.00105.0001,7140.00%
2025/03/131106.0000.00103.5011,7070.06%
2025/03/120.8107.5000.00107.000.81,6950.05%
2025/03/110.2108.9800.00107.000.21,6970.01%
2025/03/102105.504106.50107.00-21,686-0.12%
2025/03/0710108.053107.50107.5071,6650.42%
2025/03/064112.6300.00111.0041,6470.24%
2025/03/050114.5010114.75115.50-101,645-0.61%
2025/03/0400.000.1114.00114.50-0.11,634-0.01%
2025/03/032112.502114.00112.5001,6200.00%
2025/02/277113.291109.00109.0061,5680.38%
2025/02/265115.7017117.94115.50-121,553-0.77%
2025/02/251113.0000.00113.0011,4430.07%
2025/02/2400.001115.00115.00-11,431-0.07%
2025/02/210.1112.5000.00113.000.11,4120.01%
2025/02/202109.502111.00110.0001,3890.00%
2025/02/181110.004109.13110.00-31,401-0.21%
2025/02/172113.001112.50112.5011,3970.07%
2025/02/132111.0000.00111.5021,4130.14%
2025/02/122107.002109.00112.0001,4080.00%
2025/02/1116113.344109.00109.00121,3920.86%
2025/02/103120.833118.50118.5001,3370.00%
2025/02/075117.603120.50120.5021,3510.15%
2025/02/0620118.5317.1119.82119.002.91,3290.22%
2025/02/0500.000.1113.00113.00-0.11,1940.00%
2025/02/04199.5000.00103.0011,2010.08%
2025/01/1000.00196.0097.00-11,355-0.07%
2025/01/09299.05398.1394.60-11,341-0.07%
2025/01/0800.002103.00103.00-21,299-0.15%
2024/12/26192.60292.2592.50-11,225-0.08%
2024/12/17186.6000.0086.7011,2230.08%
2024/12/16188.4000.0086.3011,2160.08%
2024/12/06193.3000.0093.3011,1800.08%
2024/12/02094.7000.0094.4001,1580.00%
2024/11/29296.30196.0097.5011,1360.09%
2024/11/2800.00192.3092.40-11,110-0.09%
2024/11/25194.8000.0093.8011,0790.09%
2024/11/051100.501106.50106.0007820.00%
2024/11/0400.001100.50100.00-1758-0.13%
2024/11/013106.834.1106.09105.00-1.1730-0.15%
2024/10/301101.001102.00102.0006170.00%
2024/10/2900.001.1101.45100.50-1.1604-0.18%
2024/10/282101.25197.60102.0015760.17%
2024/10/25199.8000.0097.4015130.19%
2024/10/2400.00297.7098.30-2494-0.40%
2024/10/08192.9000.0091.1015070.20%
2024/10/0700.000.188.3288.80-0.1506-0.02%
2024/09/2600.000.487.6286.60-0.4576-0.07%
2024/09/2400.00188.7090.20-1612-0.16%
2024/08/0900.00187.1085.40-1783-0.13%
2024/08/07187.1000.0086.7017940.13%
2024/08/0600.00278.8080.80-2783-0.26%
2024/07/18198.5000.0099.4016760.15%
2024/07/1500.000.198.7098.40-0.1663-0.02%
2024/07/1100.000.295.7095.20-0.2650-0.04%
2024/07/090.197.6000.0096.300.16680.01%
2024/07/082.199.83299.45100.500.16550.02%
2024/07/01197.6000.00101.0016100.16%
2024/06/2700.00198.2095.70-1582-0.17%
2024/06/2000.00195.0094.50-1635-0.16%
2024/06/1800.00395.6095.40-3633-0.47%
2024/06/14396.1700.0095.3036550.46%
2024/06/12195.90594.2094.80-4638-0.63%
2024/06/07593.22194.5094.5046440.62%
2024/06/0400.00292.0090.80-2647-0.31%
2024/06/0300.00190.6090.70-1693-0.14%
2024/05/3100.00191.0090.60-1729-0.14%
2024/05/27191.0000.0091.7017760.13%
2024/05/20198.5000.0096.9018650.12%
2024/05/1700.00297.3097.90-2872-0.23%
2024/05/13192.40192.1092.6001,0380.00%
2024/05/0600.00293.9593.40-21,175-0.17%
2024/04/30394.7700.0093.7031,4250.21%
2024/04/2900.00194.0095.30-11,430-0.07%
2024/04/19190.0000.0089.0011,5230.07%
2024/04/16192.1000.0091.0011,5570.06%
2024/04/11198.0000.0097.9011,6150.06%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-29天前
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章
 
 
54小時59